Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
20.95
+0.04 (0.19%)
Aug 17, 2026, 1:19 PM EDT - Market open

Amphastar Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8911,2311,7852,9631,3541,114
Market Cap Growth
-37.12%-31.07%-39.75%118.80%21.52%16.65%
Enterprise Value
1,2891,6112,1653,3361,2731,106
Last Close Price
20.9126.7837.1361.8528.0223.29
PE Ratio
12.4212.5511.1921.5414.8217.94
Forward PE
6.957.789.4220.7716.2916.96
PS Ratio
1.221.712.444.602.712.55
PB Ratio
1.161.562.444.632.562.50
P/TBV Ratio
7.395.5212.60113.422.762.74
P/FCF Ratio
5.8210.1510.3620.3920.7915.80
P/OCF Ratio
4.827.888.3716.1515.1911.37
PEG Ratio
-7.010.990.920.860.89
EV/Sales Ratio
1.762.242.965.182.552.53
EV/EBITDA Ratio
6.627.328.3814.199.6311.65
EV/EBIT Ratio
9.379.8510.5416.9311.8515.43
EV/FCF Ratio
8.4213.2912.5622.9519.5515.68
Debt / Equity Ratio
0.900.830.890.980.190.24
Debt / EBITDA Ratio
3.332.852.462.590.751.05
Debt / FCF Ratio
4.505.413.784.291.581.48
Net Debt / Equity Ratio
0.520.470.590.57-0.14-0.07
Net Debt / EBITDA Ratio
2.051.701.661.56-0.55-0.34
Net Debt / FCF Ratio
2.603.082.492.52-1.12-0.45
Asset Turnover
0.440.450.470.570.710.67
Inventory Turnover
2.062.202.762.802.552.51
Quick Ratio
1.662.802.071.652.792.08
Current Ratio
2.404.023.072.173.993.06
Return on Equity (ROE)
10.30%12.90%23.26%23.55%18.76%14.16%
Return on Assets (ROA)
5.11%6.37%8.31%10.92%9.51%6.88%
Return on Invested Capital (ROIC)
9.06%11.17%15.98%21.89%19.68%13.13%
Return on Capital Employed (ROCE)
9.30%11.10%14.60%15.30%16.60%12.60%
Earnings Yield
8.83%7.97%8.94%4.64%6.75%5.57%
FCF Yield
17.19%9.85%9.65%4.91%4.81%6.33%
Buyback Yield / Dilution
7.79%7.38%1.78%-1.09%-5.31%-1.34%
SEC Filings: 10-K · 10-Q